Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization - Wikidata - awgldk - TriplyDB

Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization

Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization

http://www.wikidata.org/entity/Q36837815

about

Few and far between: how HIV may be evading antibody avidity Cryoelectron tomography of HIV-1 envelope spikes: further evidence for tripod-like legs Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site A Conformational Switch in Human Immunodeficiency Virus gp41 Revealed by the Structures of Overlapping Epitopes Recognized by Neutralizing Antibodies Functional stability of unliganded envelope glycoprotein spikes among isolates of human immunodeficiency virus type 1 (HIV-1)A human antibody to the CD4 binding site of gp120 capable of highly potent but sporadic cross clade neutralization of primary HIV-1.Estimating the probability of polyreactive antibodies 4E10 and 2F5 disabling a gp41 trimer after T cell-HIV adhesion.Soluble CD4 and CD4-mimetic compounds inhibit HIV-1 infection by induction of a short-lived activated state.Multi-Parameter Exploration of HIV-1 Virus-Like Particles as Neutralizing Antibody Immunogens in Guinea Pigs, Rabbits and Macaques In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1 Antibody to gp41 MPER alters functional properties of HIV-1 Env without complete neutralization Three-dimensional structures of soluble CD4-bound states of trimeric simian immunodeficiency virus envelope glycoproteins determined by using cryo-electron tomography Envelope-modified single-cycle simian immunodeficiency virus selectively enhances antibody responses and partially protects against repeated, low-dose vaginal challenge Comparative Immunogenicity of Evolved V1V2-Deleted HIV-1 Envelope Glycoprotein Trimers Structure-based vaccine design in HIV: blind men and the elephant?Enzyme digests eliminate nonfunctional Env from HIV-1 particle surfaces, leaving native Env trimers intact and viral infectivity unaffected.Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1 HIV type 1 Env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies.Intra-spike crosslinking overcomes antibody evasion by HIV-1 Intraprotomer masking of third variable loop (V3) epitopes by the first and second variable loops (V1V2) within the native HIV-1 envelope glycoprotein trimer.Targeting HIV-1 envelope glycoprotein trimers to B cells by using APRIL improves antibody responses.Acquisition of CD4-dependence by CD4-independent SIV passaged in human peripheral blood mononuclear cells Proteolytic processing of the human immunodeficiency virus envelope glycoprotein precursor decreases conformational flexibility Inhibition of the HIV-1 spike by single-PG9/16-antibody binding suggests a coordinated-activation model for its three protomeric units Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C.Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan.Determinants flanking the CD4 binding loop modulate macrophage tropism of human immunodeficiency virus type 1 R5 envelopes HIV-1 virus-like particles bearing pure env trimers expose neutralizing epitopes but occlude nonneutralizing epitopes.Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization Structure of Simian Immunodeficiency Virus Envelope Spikes Bound with CD4 and Monoclonal Antibody 36D5.Yeast-elicited cross-reactive antibodies to HIV Env glycans efficiently neutralize virions expressing exclusively high-mannose N-linked glycans.

P2860

Q21090507-DA334E5D-BD6C-4242-96C8-20C2FCB305DB Q21090520-3ECE863F-3F7A-43D8-8434-DD6EC662F68E Q24635002-93AEADC7-6CA1-4391-941E-9096D6447E66 Q26775082-A3474AC1-8067-4C59-AB7F-475284E5296A Q27319450-E543E6FD-8AF8-401E-B3CD-8E1FC8935C7C Q27655865-E89BBB6B-E66C-425D-A627-AC28ABFF3CEF Q28743199-ED82C9F7-1F2D-4B5C-8C41-D2FC0EDE2C1F Q31132248-FED330B9-E558-4A95-9F67-9C6A52F60AE9 Q31151010-96403799-3427-4D65-A5F6-271AEBE11F51 Q33426352-43FB995B-4854-468B-8667-81BA15609168 Q33683203-786FBDCD-B36B-48FB-9201-0EC929696163 Q33725718-FB5BE97D-0256-428C-BDC2-466B18DBFCAE Q33946158-5263BFAF-66F0-4C4A-A916-63C84EAD3701 Q34027126-866E60B8-6A02-4F0B-ADFB-28CF4D4B755D Q34178259-3A4271A5-64B2-4D06-9870-E6F32E398145 Q34807480-A60142F4-0E42-4511-B622-A9C34ED54174 Q34987048-C1CC130A-23C8-4203-AD8D-F91CB7A0AAB6 Q35076987-8E5ACCCB-3996-486A-9FE9-CB59B244C239 Q35122067-7EC05680-709F-4D93-B777-F0B24B49EFCF Q35173635-0F2EACE8-B6A7-4D3F-885B-7E265CF7F85C Q35462906-A5D45961-0047-4852-B957-B707436CEEB9 Q35647772-E2BEF693-1ECC-404C-9C7E-3DB75AE7EBF1 Q35826171-E7866556-34F6-4109-B8FE-A056E9FBB0B9 Q36162633-7E20D7DF-9D64-49F0-BFC3-245B37B34B5C Q36559735-145840ED-AB6D-4B27-B650-035732A22EF1 Q36911746-0CFB30DA-F940-4E33-8B25-935AA1E3DB91 Q36974754-9D985669-B6B5-43FB-B30E-7C7DF593AD69 Q38753943-17F23280-C568-402B-A662-061248D8F767 Q38979142-3765F41D-1FD4-4A28-BF52-8ECDF0A7241F Q39402539-2E6ACD4B-2F02-456B-909F-63A9819498B2 Q39723388-BF71487D-E822-4272-AB9A-E788F123CD92 Q40187598-949925ED-A57F-47AC-A59A-199BDB832B61 Q41592410-63B71045-7363-4CEB-80F7-1A30B5003491

P2860

Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization

http://www.wikidata.org/entity/Q36837815

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization

@en

type

label

Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization

@en

prefLabel

Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization

@en

P1433

Q36837815-97754A3A-EDA6-44C0-BFC9-5FAD5C85FA7E

P1476

Q36837815-66B8E061-3290-4EC6-BAA1-462198EC9A05

P2093

Q36837815-02CA3CD7-4A8E-4AEC-B0D0-9AAE060310B0

Q36837815-55D44716-AC65-444E-BCCA-4DA6BC29D2FF

Q36837815-59012063-DD89-48B4-B082-63B4399FD871

Q36837815-5C526AE2-A291-4CD9-A9B2-01035E5F1711

Q36837815-69C3D43E-B0D4-4747-8A34-BF716DD4DA14

Q36837815-C689FCB5-52DE-4ECD-A170-F92B9F9867C4

Q36837815-C8A80E48-6000-4DBD-8C66-F54BF13B27FE

Q36837815-FC76FB27-D903-4AFB-8BB4-A942BFB15BDD

P2860

Q36837815-07629D4D-1E04-4FF8-9AAD-48066BB5D446

Q36837815-0B33CE0F-7757-407A-ADA9-B9ECDDB2D822

Q36837815-0C438934-E67F-4B88-B606-76E4595D6772

Q36837815-0C72E584-C9F2-4035-BA09-7D4A697C21FF

Q36837815-0CB83571-D4DF-4875-B182-F75E4614DBD6

Q36837815-0DAF6C68-410E-459F-B380-A495D693D3D2

Q36837815-12F1BFB8-6FE9-44CC-A4E4-494D34EA9002

Q36837815-17FA2761-5E23-4EBF-8A7B-5AE2EC705B99

Q36837815-19776654-3088-49FE-BE4A-BA5D44EBAB9E

Q36837815-1B497ADB-3EA8-493D-980A-5C80027DD9BC

P304

Q36837815-F7013524-C56F-41B9-B83D-58E44160581C

P31

Q36837815-EF215BDA-9C42-455D-BE03-E8E30277B5FC

P356

Q36837815-8236C626-117E-4921-9AF9-6363CC75DEBC

P407

Q36837815-2FB168D1-25F5-420A-AAC6-8F3A73048994

P433

Q36837815-E8AA7039-62C8-4532-9726-B31254F1ABA8

P478

Q36837815-8CFA4C44-C312-4705-9B0A-3473DE26FA59

P50

Q36837815-5D8014CE-C303-48E2-99CF-BFCE8F44EDEB

P577

Q36837815-CFD94842-0EF5-487A-888E-B3457692CDD2

P5875

Q36837815-0EBE76E8-CF4F-4421-B817-78F4E16CB196

P698

Q36837815-EF99CCB2-C17A-4AA5-8EB6-DB3578713004

P932

Q36837815-BCC305D7-C1A4-4A48-B1E3-813DD6069342

P356

J.VIROL.2008.04.045

P1433

P1476

Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization

@en

P2093

Emma T Crooks

http://www.w3.org/2001/XMLSchema#string

James A Hoxie

http://www.w3.org/2001/XMLSchema#string

James E Robinson

http://www.w3.org/2001/XMLSchema#string

James M Binley

http://www.w3.org/2001/XMLSchema#string

Michael B Zwick

http://www.w3.org/2001/XMLSchema#string

Michael Franti

http://www.w3.org/2001/XMLSchema#string

Pengfei Jiang

http://www.w3.org/2001/XMLSchema#string

Sharon Wong

http://www.w3.org/2001/XMLSchema#string

P2860

Cryo-electron tomographic structure of an immunodeficiency virus envelope complex in situ

Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies

Multimeric CD4 binding exhibited by human and simian immunodeficiency virus envelope protein dimers

Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1

Structural definition of a conserved neutralization epitope on HIV-1 gp120

The human immunodeficiency virus type 1 gp120 V2 domain mediates gp41-independent intersubunit contacts.

A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies

Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design

Antibody domain exchange is an immunological solution to carbohydrate cluster recognition

Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope

P304

364-378

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VIROL.2008.04.045

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

377

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5316790

http://www.w3.org/2001/XMLSchema#string

P698

18539308

http://www.w3.org/2001/XMLSchema#string

P932

2516379

http://www.w3.org/2001/XMLSchema#string